CatalystPit

ALDXAldeyra Therapeutics, Inc.

NASDAQ · PHARMACEUTICAL PREPARATIONS
Last close $1.23 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$74.20M
CountryUSA
RECENT INSIDER TRADES
  • 2026-06-05 · Brady Todd C (President and CEO) · BUY
  • 2026-03-20 · DOUGLAS RICHARD (Director) · BUY
  • 2026-03-19 · Alfieri Michael (Principal Financial Officer) · BUY
  • 2025-08-15 · Alfieri Michael (Principal Financial Officer) · BUY
  • 2025-08-13 · Machatha Stephen (Chief Development Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders121
Shares held45,090,454
Value$111.75M
Percent of shares outstanding74.74%
As of quarter end2026-06-30
RECENT NEWS
  • Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease - Slideshow
  • Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease Transcript
  • Aldeyra Therapeutics to appeal FDA rejection of reproxalap
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS